TNDM as reported
Tandem Diabetes Care, Inc. reported $1.03B of revenue over the trailing twelve months, +4.5% on the year before. 10 reported series are charted on this page, each one as filed.
$1.03B
Revenue, trailing twelve months · to Q1 2026 · +4.5% against the twelve months before
- Net Income
- −$95M
Net Income · −49% year on year · trailing twelve months to Q1 2026
- Free Cash Flow
- −$3.6M
Free Cash Flow · −4.1% year on year · trailing twelve months to Q1 2026
- Op Margin
- −8.7%
Op Margin · trailing twelve months to Q1 2026
| Series | Latest | Year on year | As of |
|---|---|---|---|
| Revenue | $1.03B | +4.5% | Q1 2026 |
| Net Income | −$95M | −49% | Q1 2026 |
| EPS | −$1.40 | −50% | Q1 2026 |
| Gross Margin | 55% | n/a | Q1 2026 |
| Op Margin | −8.7% | n/a | Q1 2026 |
| Net Margin | −9.7% | n/a | Q1 2026 |
| ROE | −128% | n/a | Q1 2026 |
| ROA | −20% | n/a | Q1 2026 |
| ROIC | −94% | n/a | Q1 2026 |
| Free Cash Flow | −$3.6M | −4.1% | Q1 2026 |
Every figure straight from the statements as filed with the SEC, no scoring, no adjustment. Open a series for its full history.
Tandem Diabetes Care, Inc. (TNDM) - Revenue & ProfitRevenue & ProfitTandem Diabetes Care, Inc. (TNDM)
Revenue (TTM)Net Income (TTM)
Powered byryufin.com